Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2023 and 2024.
-
Tight liquidity NBB
Cash and receivables cover 54 % of short-term debt in 2024; threshold 65 %.
Financials
Financial year 2024
FARMACOM from Schoten, company number BE0431933575, closed financial year 2024 with a result of € -5,797 after tax. For that financial year FARMACOM recorded a gross margin of € 38,789 and equity of € 669,979. Compared with financial year 2023, the result moved from € -15,872 to € -5,797. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 8, 2025.
€ 669,979
▼ 1% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -5,797
▲ 63 % less loss than in 2023
Profit after tax over the fiscal year.
€ 67,598
▼ 76% vs 2023
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -103,448.
Debts at end 2024
None
No bank loans on the last day of the fiscal year.
€ 1,706
Supplier invoices still open on the last day of the fiscal year.
| 2021 | 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|---|
| Gross margin | € 231,652 | € 24,400 | € 33,366 | € 38,789 | ▲ 16% |
| Profit after taxes | € 196,067 | € -21,658 | € -15,872 | € -5,797 | ▲ € 10,074 |
| Equity | € 713,306 | € 691,648 | € 675,777 | € 669,979 | ▼ 1% |
| Total debts | € 265,547 | € 225,569 | € 180,856 | € 139,490 | ▼ 23% |
| Cash | € 383,595 | € 353,810 | € 280,870 | € 67,598 | ▼ 76% |
| Land & buildings | € 604,714 | € 569,102 | € 575,468 | € 538,670 | ▼ 6% |
| Retained profit | € -60,122 | € -81,779 | € -97,651 | € -103,448 | ▼ € 5,797 |
| Balance sheet total | € 997,037 | € 932,216 | € 868,445 | € 818,096 | ▼ 6% |
Key figures of FARMACOM, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to FARMACOM?
What happened at FARMACOM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2024: loss of € 5,797. filed late Source: NBB ↗
- New establishment in Antwerpen. KBO
- Start of the company according to the CBE. KBO
In short
From € 196,067 profit in 2021 to € 5,797 loss in 2024.
Best year ever: 2021, with € 196,067 profit.
Management
Behind FARMACOM are Magdalena Vandaele and Tom Ponnet. Tom Ponnet is also behind TOMACO, Turbocast Medical and WARNER BOWES HOLDING.
Directors
According to the 2024 annual accounts
Magdalena Vandaele
Director
Establishments
Establishment units
Physical locations of this company
Hertendreef 37
2900 Schoten
Statiestraat 90 9
2600 Antwerpen
Active since 21 February 1989
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0431.933.575
- VAT number
- BE 0431.933.575
- Registered office
- Hertendreef 37, 2900 Schoten
- Names & denominations
- FARMACOM
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 4 September 1987
- Peppol
- Active · Active since 7 Oct 2025